INFLUVAC min. 15mcg of each vaccine suspension for injection in pre-filled syringe medication leaflet

J07BB02 inactivated influenza vaccine • Antiinfectives for systemic use | Viral vaccines | Influenza vaccines

The inactivated influenza vaccine is used to prevent seasonal flu, a viral illness caused by influenza viruses of types A and B. The vaccine contains inactivated influenza viruses that cannot cause the disease but stimulate the immune system to produce specific antibodies against influenza viruses.

The vaccine is administered intramuscularly or subcutaneously, usually annually, and is recommended for all individuals over 6 months of age, especially those in high-risk groups such as the elderly, pregnant women, individuals with chronic illnesses, and healthcare workers.

Common side effects include pain at the injection site, mild fever, fatigue, and muscle aches. In rare cases, severe allergic reactions may occur.

The inactivated influenza vaccine is an important preventive measure for reducing the incidence and severity of seasonal flu, helping to protect public health and alleviate the burden on healthcare systems.

General data about INFLUVAC min. 15mcg of each vaccine

Substance: inactivated influenza vaccine

Date of last drug list: 01-03-2022

Commercial code: W65634001

Concentration: min. 15mcg of each vaccine

Pharmaceutical form: suspension for injection in pre-filled syringe

Quantity: 1

Product type: original

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: ABBOTT BIOLOGICALS B.V. - OLANDA

Holder: MYLAN HEALTHCARE GMBH - GERMANIA

Number: 6963/2014/01

Shelf life: 1 year

Pharmaceutical forms available for inactivated influenza vaccine

Concentrations available for inactivated influenza vaccine

15mcg/strain, 9mcg/strain, min. 15mcg of each vaccine, min. 15mcgof each vaccine, min.15mcgHA ptr. fiecare tip

Other substances similar to inactivated influenza vaccine